NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 14, 2023 $0.217 +15.58% $0.200 V 91.36% 1
Dec 14, 2023 Bullish $0.200 V 1
JS JS Pro
Dec 13, 2023 $0.267 +42.78% $0.188 V 57.98% 1
Dec 13, 2023 $0.237 +26.69% $0.188 V 73.98% 1
Dec 13, 2023 $0.218 +16.68% $0.188 V 83.94% 1
JS JS Pro
Dec 11, 2023 $0.234 +9.65% $0.196 X 80.73% 0
Dec 11, 2023 $0.269 +26.17% $0.196 X 62.77% 0
Dec 11, 2023 $0.248 +16.36% $0.196 X 73.44% 0
Zack Holt Zack Holt @ZackHolt.185052
Dec 11, 2023 Bullish $0.196 X 0
Dec 11, 2023 Bullish $0.196 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE